Robles, Ana I.
National Cancer Institute (NCI),
United States
2025 Rank: 223817
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 6972 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 223817 | 230576 |
| Total Cites | 1488 | 1655 |
| H-index | 20 | 22 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 63 | 65 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 66 | 68 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1215 | 1282 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.29 |
| Self-Citation Percentage |
10.09%
|
|
Robles, Ana I.
National Cancer Institute (NCI),
United States
2024 Rank: 185070
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 6114 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 185070 | 204619 |
| Total Cites | 1323 | 1546 |
| H-index | 19 | 19 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 65 | 66 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 76 | 77 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1087 | 1171 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.32 |
| Self-Citation Percentage |
14.42%
|
|
Robles, Ana I.
National Cancer Institute (NCI),
United States
2023 Rank: 169101
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 6061 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 169101 | 188845 |
| Total Cites | 1260 | 1356 |
| H-index | 18 | 18 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 79 | 83 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 92 | 96 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1059 | 1107 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.22 |
| Self-Citation Percentage |
7.08%
|
|
Robles, Ana I.
National Cancer Institute (NCI),
United States
2022 Rank: 139122
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 5233 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 139122 | 151627 |
| Total Cites | 961 | 1090 |
| H-index | 16 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 100 | 102 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 116 | 118 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 870 | 935 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.17 |
| Self-Citation Percentage |
11.83%
|
|